Skip to main content

Table 1 Hemodynamic variables of malignant hyperthermia susceptible (MHS) and non-susceptible (MHN) pigs following succinylcholine or halothane or succinylcholine and halothane application

From: The effect of succinylcholine on malignant hyperthermia events in susceptible swine

Diagnose

Time [min|

HR [bpm]

MAP [mmHg]

SaO2[%]

etCO2[mmHg]

Temperature [°C]

MHSSCh (n = 9)

0 min

53 [52–61]

84 [83–89]

98 [98–98]

35 [31–35]

37,3 [37,1-37,3]

15 min

58 [53–65]

85 [82–89]

98 [97–98]

35 [32–36]

37,2 [37,0-37,3]

30 min

73 [63–85]*

67 [55–74]*

98 [97–98]

48 [42–51]*#

37,5 [37,2-37,5]

 

45 min

70 [68–92]*

66 [60–76]*

98 [97–98]

54 [44–62]*#

37,6 [37,3-37,9]

MHNSCh (n = 10)

0 min

67 [63–72]

75 [70–86]

99 [97–100]

33 [30–35]

37,0 [36,8-37,5]

15 min

71 [63–75]

74 [67–81]

99 [96–100]

33 [30–35]

36,9 [36,7-37,4]

30 min

72 [67–75]

72 [68–76]

99 [98–100]

34 [31–34]

37,0 [36,6-37,4]

 

45 min

66 [61–70]

71 [69–76]

99 [97–100]

34 [31–35]

37,0 [36,6-37,4]

MHSHalothane (n = 6)

0 min

61 [60–66]

82 [75–84]

98 [98–99]

33 [30–35]

37,4 [36,9-37,5]

15 min

58 [55–66]

82 [76–87]

98 [97–99]

33 [30–34]

37,4 [36,9-37,4]

30 min

61 [59–64]

49 [45–53]*#

98 [97–99]

36 [32–40]*

37,3 [37,0-37,5]

 

45 min

76 [61–110]

41 [38–45]*

97 [95–98]

55 [44–65]*

37,5 [37,1-37,9]

MHNHalothane (n = 10)

0 min

64 [57–70]

72 [70–79]

98 [98–100]

33 [31–35]

36,8 [36,6-37,3]

15 min

64 [55–69]

73 [68–80]

98 [97–99]

35 [31–35]

37,0 [36,8-37,2]

30 min

68 [61–76]

66 [55–72]*

99 [98–100]

33 [31–34]

37,1 [36,6-37,2]

 

45 min

69 [62–73]

51 [45–56]*

99 [97–100]

31 [29–33]*#

37,0 [36,8-37,3]

MHSHalothane+SCh (n = 12)

0 min

65 [55–87]

60 [59–72]

98 [98–99]

31 [30–32]

37,5 [37,4-37,9]

15 min

80 [70–92]*

60 [55–75]

98 [97–99]

33 [32–34]*

37,5 [37,3-37,8]

30 min

168 [113–204]*#

41 [35–45]*

96 [95–98]*

63 [55–65]*#

38,0 [37,6-38,2]*#

 

45 min

200+

60+

98+

79+

39,5+

MHNHalothane+SCh (n = 10)

0 min

71 [61–79]

67 [60–80]

99 [97–99]

33 [31–33]

37,6 [37,1-37,8]

15 min

83 [73–97]*

61 [60–78]

98 [97–99]

32 [31–34]

37,2 [37,1-37,6]*

30 min

93 [84–102]*

57 [53–60]*

98 [96–98]

31 [30–32]

37,0 [36,8-37,5]*

 

45 min

100 [95–105]*

52 [48–60]*

96 [95–100]

32 [30–32]

36,9 [36,7-37,4]*

  1. t = 0 minutes: Baseline values; t = 15 minutes: Application of 4 mg/kg succinylcholine or 0.5 vol% halothane or both; t = 30 minutes: Application of 4 mg/kg succinylcholine or 1 vol% halothane or both.
  2. HR = heart rate; MAP = mean arterial blood pressure; SaO2 = peripheral oxygen saturation; etCO2 = end-tidal carbon dioxide; SCh = succinylcholine.
  3. Data as median and interquartile range;
  4. *significant changes from baseline values; #significant differences between MHS and MHN; p < 0.05. +: data from only one MHS animal.